SYRE vs TRMB vs KEYS vs ARRY

For growth investors, Array Technologies, Inc.

(ARRY) is the stronger pick with 40. 2% revenue growth year-over-year, versus -2. 6% for Trimble Inc. (TRMB). Trimble Inc. (TRMB) offers the better valuation at 35. 3x trailing P/E (20. 0x forward), making it the more compelling value choice. Analysts rate Spyre Therapeutics, Inc. (SYRE) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Trimble Inc.

(TRMB) is the cheapest at 35. 3x versus Keysight Technologies, Inc. at 72. 7x. On forward P/E, Array Technologies, Inc. is actually cheaper at 11. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Keysight Technologies, Inc. wins at 4. 97x versus Trimble Inc. 's 8. 15x.

Over the past 5 years, Keysight Technologies, Inc.

(KEYS) delivered a total return of +147. 4%, compared to -67. 7% for Array Technologies, Inc. (ARRY). Over 10 years, the gap is even starker: KEYS returned +1279% versus ARRY's -77. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Trimble Inc.

(TRMB) is the lower-risk stock at 1. 46β versus Array Technologies, Inc. 's 2. 32β — meaning ARRY is approximately 58% more volatile than TRMB relative to the S&P 500. On balance sheet safety, Trimble Inc. (TRMB) carries a lower debt/equity ratio of 24% versus 3% for Array Technologies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Array Technologies, Inc.

(ARRY) is pulling ahead at 40. 2% versus -2. 6% for Trimble Inc. (TRMB). On earnings-per-share growth, the picture is similar: Array Technologies, Inc. grew EPS 62. 6% year-over-year, compared to -71. 3% for Trimble Inc.. Over a 3-year CAGR, KEYS leads at -0. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Keysight Technologies, Inc.

(KEYS) is the more profitable company, earning 15. 7% net margin versus -198. 3% for Spyre Therapeutics, Inc. — meaning it keeps 15. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KEYS leads at 17. 6% versus -256. 0% for SYRE. At the gross margin level — before operating expenses — TRMB leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Keysight Technologies, Inc. (KEYS) is the more undervalued stock at a PEG of 4. 97x versus Trimble Inc. 's 8. 15x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Array Technologies, Inc. (ARRY) trades at 11. 7x forward P/E versus 39. 8x for Keysight Technologies, Inc. — 28. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRMB: 53. 6% to $95. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Keysight Technologies, Inc.

(KEYS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1279% 10Y return). Array Technologies, Inc. (ARRY) carries a higher beta of 2. 32 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KEYS: +1279%, ARRY: -77. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SYRE (Healthcare) and TRMB (Technology) and KEYS (Technology) and ARRY (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SYRE is a mid-cap quality compounder stock; TRMB is a mid-cap quality compounder stock; KEYS is a mid-cap quality compounder stock; ARRY is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.